A Look At Nurix Therapeutics (NRIX) Valuation After Strong 1 Year Return And High Price To Sales Ratio [Yahoo! Finance]
Nurix Therapeutics, Inc. - Common stock (NRIX)
Company Research
Source: Yahoo! Finance
What Nurix Therapeutics Stock's Recent Performance Tells You Nurix Therapeutics (NRIX) has caught investor attention after a mixed stretch, with a small 1 day gain, a strong 1 year total return of 60.06%, and a 14.12% decline over the past 3 months. See our latest analysis for Nurix Therapeutics. The recent 7 day share price return of 5.08% comes after a weaker 90 day share price return, with a decline of 14.12%. However, the 1 year total shareholder return of 60.06% suggests that longer term holders have still seen strong gains. If this kind of rebound catches your interest, it could be a good moment to widen your watchlist with a dedicated screener of 36 healthcare AI stocks With Nurix Therapeutics trading at a market value of about US$1.6b and a recent close of US$15.51, the key question is whether current prices already reflect its clinical pipeline and partnerships, or if markets are leaving room for a fresh buying opportunity. Preferred Multiple of 19.1x Price-to-Sa
Show less
Read more
Impact Snapshot
Event Time:
NRIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NRIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NRIX alerts
High impacting Nurix Therapeutics, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
NRIX
News
- Wells Fargo Cuts PT on Nurix Therapeutics (NRIX) to $28 From $29 [Yahoo! Finance]Yahoo! Finance
- Nurix Therapeutics (NRIX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.MarketBeat
- Nurix: 'Strong Buy' Bexobruditeg Development And Dual Degrader Zelebrudomide [Seeking Alpha]Seeking Alpha
- Nurix Therapeutics (NRIX) had its price target lowered by Wells Fargo & Company from $29.00 to $28.00. They now have an "overweight" rating on the stock.MarketBeat
- Nurix Therapeutics (NRIX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $26.00 price target on the stock.MarketBeat
NRIX
Earnings
- 1/28/26 - Beat
NRIX
Sec Filings
- 4/8/26 - Form 10-Q
- 4/8/26 - Form 8-K
- 4/2/26 - Form 4
- NRIX's page on the SEC website